Lung Cancer
A phase 3 randomized, open-label, multicenter study evaluating the efficacy and safety of divarasib versus sotorasib or adagrasib in patients with previously treated KRAS G12C-positive advanced or metastatic Non-Small Cell Lung Cancer (BO45217)
- Details
ClinicalTrials.gov ID:
NCT06497556
Diagnosis Type:
NA
USOR Number:
- Address
,
P: